• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FOXM1c是胆管癌中表达的主要FOXM1亚型,与患者的转移潜能和不良预后相关。

FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients.

作者信息

Klinhom-On Nathakan, Seubwai Wunchana, Sawanyawisuth Kanlayanee, Lert-Itthiporn Worachart, Waraasawapati Sakda, Detarya Marutpong, Wongkham Sopit

机构信息

Department of Biochemistry, Faculty of Medicine, Khon Kaen University, 40002, Thailand.

Department of Forensic Medicine, Faculty of Medicine, Khon Kaen University, 40002, Thailand.

出版信息

Heliyon. 2021 Apr 22;7(4):e06846. doi: 10.1016/j.heliyon.2021.e06846. eCollection 2021 Apr.

DOI:10.1016/j.heliyon.2021.e06846
PMID:33997388
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8093466/
Abstract

Forkhead box M1 (FOXM1) is a transcriptional factor which plays an important role in oncogenesis. Four FOXM1 isoforms, FOXM1a, FOXM1b, FOXM1c and FOXM1d, are known so far. Different FOXM1 isoforms influence progression of cancer in different cancer types. In this study, the FOXM1c isoform and its impact in cholangiocarcinoma (CCA) was identified. FOXM1c was found to be the predominant isoform in patient-CCA tissues and cell lines. Detection of FOXM1c expression in CCA tissues reflected the worse prognosis of the patients, namely the advanced stage and shorter survival. Suppression of FOXM1 expression using siRNA considerably reduced migration and invasion abilities of CCA cell lines. RNA sequencing analysis revealed claudin-1 as a target of FOXM1. FOXM1 exhibited a negative correlation with claudin-1 expression which was demonstrated in patient CCA tissues and cell lines. FOXM1 may be a potential target for therapeutic treatment of the metastatic CCA.

摘要

叉头框蛋白M1(FOXM1)是一种转录因子,在肿瘤发生过程中发挥重要作用。目前已知有四种FOXM1亚型,即FOXM1a、FOXM1b、FOXM1c和FOXM1d。不同的FOXM1亚型在不同类型的癌症中对癌症进展产生不同影响。在本研究中,鉴定了FOXM1c亚型及其在胆管癌(CCA)中的作用。研究发现FOXM1c是患者CCA组织和细胞系中的主要亚型。检测CCA组织中FOXM1c的表达反映了患者预后较差,即处于晚期且生存期较短。使用小干扰RNA(siRNA)抑制FOXM1表达可显著降低CCA细胞系的迁移和侵袭能力。RNA测序分析显示,闭合蛋白-1(claudin-1)是FOXM1的一个靶点。在患者CCA组织和细胞系中证实,FOXM1与claudin-1表达呈负相关。FOXM1可能是转移性CCA治疗的一个潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/8093466/97e38803cf81/figs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/8093466/ce99192982cc/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/8093466/ff2bbf7bc34f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/8093466/1eada5a2076b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/8093466/63a6730ddd02/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/8093466/fb69f31c62b6/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/8093466/97e38803cf81/figs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/8093466/ce99192982cc/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/8093466/ff2bbf7bc34f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/8093466/1eada5a2076b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/8093466/63a6730ddd02/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/8093466/fb69f31c62b6/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a6f/8093466/97e38803cf81/figs2.jpg

相似文献

1
FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients.FOXM1c是胆管癌中表达的主要FOXM1亚型,与患者的转移潜能和不良预后相关。
Heliyon. 2021 Apr 22;7(4):e06846. doi: 10.1016/j.heliyon.2021.e06846. eCollection 2021 Apr.
2
Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer.FOXM1 异构体表达失调驱动胰腺癌进展。
Cancer Res. 2013 Jul 1;73(13):3987-96. doi: 10.1158/0008-5472.CAN-12-3859. Epub 2013 Apr 18.
3
FOXM1b, which is present at elevated levels in cancer cells, has a greater transforming potential than FOXM1c.FOXM1b 在癌细胞中呈高水平表达,其转化潜能大于 FOXM1c。
Front Oncol. 2013 Jan 31;3:11. doi: 10.3389/fonc.2013.00011. eCollection 2013.
4
FOXM1c promotes oesophageal cancer metastasis by transcriptionally regulating IRF1 expression.FOXM1c 通过转录调控 IRF1 表达促进食管癌转移。
Cell Prolif. 2019 Mar;52(2):e12553. doi: 10.1111/cpr.12553. Epub 2018 Nov 28.
5
Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c.Raf/MEK/MAPK信号传导刺激FOXM1c的核转位和反式激活活性。
J Cell Sci. 2005 Feb 15;118(Pt 4):795-806. doi: 10.1242/jcs.01657. Epub 2005 Jan 25.
6
High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma.高葡萄糖通过 EGFR/STAT3 依赖性激活上调 FOXM1 表达,促进胆管癌的进展。
Life Sci. 2021 Apr 15;271:119114. doi: 10.1016/j.lfs.2021.119114. Epub 2021 Jan 26.
7
FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.FOXM1 通过调控 KIF4A 的表达促进肝癌进展。
J Exp Clin Cancer Res. 2019 May 9;38(1):188. doi: 10.1186/s13046-019-1202-3.
8
Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells.基于喹啉的氯碘羟喹和硝氧喹啉在胆管癌细胞中表现出抗癌活性,可诱导叉头框蛋白M1(FoxM1)受到抑制。
Drug Des Devel Ther. 2015 Apr 8;9:2033-47. doi: 10.2147/DDDT.S79313. eCollection 2015.
9
DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling.DLX1作为FOXM1的关键靶点,通过增强TGF-β/SMAD4信号传导来促进卵巢癌的侵袭性。
Oncogene. 2017 Mar;36(10):1404-1416. doi: 10.1038/onc.2016.307. Epub 2016 Sep 5.
10
Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer.泛癌分析揭示癌症中FOXM1过表达的基因组特征。
Cancers (Basel). 2019 Feb 21;11(2):251. doi: 10.3390/cancers11020251.

引用本文的文献

1
Research progress on FOXM1 in ovarian cancer diagnosis and therapeutics.FOXM1在卵巢癌诊断与治疗中的研究进展
Front Oncol. 2025 Jun 19;15:1598868. doi: 10.3389/fonc.2025.1598868. eCollection 2025.
2
Thiostrepton suppresses intrahepatic cholangiocarcinoma progression via FOXM1-mediated tumor-associated macrophages reprogramming.硫链丝菌素通过FOXM1介导的肿瘤相关巨噬细胞重编程抑制肝内胆管癌进展。
Transl Oncol. 2025 Apr;54:102327. doi: 10.1016/j.tranon.2025.102327. Epub 2025 Feb 21.
3
HNRNPC mediates lymphatic metastasis of cervical cancer through m6A-dependent alternative splicing of FOXM1.

本文引用的文献

1
Cholangiocarcinoma 2020: the next horizon in mechanisms and management.胆管癌 2020:机制和管理的新前沿。
Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588. doi: 10.1038/s41575-020-0310-z. Epub 2020 Jun 30.
2
PI3K activation is enhanced by FOXM1D binding to p110 and p85 subunits.FOXM1D与p110和p85亚基结合可增强PI3K的激活。
Signal Transduct Target Ther. 2020 Jun 30;5(1):105. doi: 10.1038/s41392-020-00218-3.
3
Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient.
HNRNPC 通过 FOXM1 的 m6A 依赖性可变剪接介导宫颈癌的淋巴转移。
Cell Death Dis. 2024 Oct 7;15(10):732. doi: 10.1038/s41419-024-07108-4.
4
FOXM1 promotes the progression of non-small cell lung cancer by inhibiting miR-509-5p expression via binding to the miR-509-5p promoter region.FOXM1通过与miR-509-5p启动子区域结合抑制其表达,从而促进非小细胞肺癌的进展。
Heliyon. 2024 Feb 27;10(5):e27147. doi: 10.1016/j.heliyon.2024.e27147. eCollection 2024 Mar 15.
5
Protein regulator of cytokinesis 1 accentuates cholangiocarcinoma progression via mTORC1-mediated glycolysis.细胞分裂蛋白调节剂 1 通过 mTORC1 介导的糖酵解促进胆管癌进展。
Hum Cell. 2024 May;37(3):739-751. doi: 10.1007/s13577-024-01032-7. Epub 2024 Feb 28.
6
FOXM1a Isoform of Oncogene FOXM1 Is a Tumor Suppressor Suppressed by hnRNP C in Oral Squamous Cell Carcinoma.癌基因 FOXM1a 异构体是口腔鳞状细胞癌中受 hnRNP C 抑制的肿瘤抑制因子。
Biomolecules. 2023 Aug 30;13(9):1331. doi: 10.3390/biom13091331.
7
FOXM1: A small fox that makes more tracks for cancer progression and metastasis.FOXM1:一个制造更多癌症进展和转移轨迹的小狐狸。
Semin Cancer Biol. 2023 Jul;92:1-15. doi: 10.1016/j.semcancer.2023.03.007. Epub 2023 Mar 22.
8
A narrative review of research progress on FoxM1 in breast cancer carcinogenesis and therapeutics.关于FoxM1在乳腺癌发生发展及治疗中的研究进展的叙述性综述。
Ann Transl Med. 2021 Nov;9(22):1704. doi: 10.21037/atm-21-5271.
从一位华支睾吸虫相关胆管癌患者的单个肿瘤中分离得到的三个细胞系的功能和遗传特征。
Hum Cell. 2020 Jul;33(3):695-708. doi: 10.1007/s13577-020-00334-w. Epub 2020 Mar 23.
4
Claudin-1, A Double-Edged Sword in Cancer.Claudin-1,癌症的双刃剑。
Int J Mol Sci. 2020 Jan 15;21(2):569. doi: 10.3390/ijms21020569.
5
The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling.O-糖基转移酶 GALNT5 通过激活 AKT/ERK 信号通路促进胆管癌的发生发展。
Glycobiology. 2020 Apr 20;30(5):312-324. doi: 10.1093/glycob/cwz098.
6
Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway.末端岩藻糖通过 EGF/EGFR 激活和 Akt/Erk 信号通路促进人胆管癌的进展。
Sci Rep. 2019 Nov 21;9(1):17266. doi: 10.1038/s41598-019-53601-8.
7
Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma.FoxM1的过表达预示着肝内胆管癌的预后不良。
Aging (Albany NY). 2018 Dec 21;10(12):4120-4140. doi: 10.18632/aging.101706.
8
O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma.O-GlcNAc 诱导 hnRNP-K 的核转位与胆管癌的进展和转移有关。
Mol Oncol. 2019 Feb;13(2):338-357. doi: 10.1002/1878-0261.12406. Epub 2019 Jan 10.
9
FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension.FOXM1 促进肺动脉高血压中的肺动脉平滑肌细胞扩张。
J Mol Med (Berl). 2018 Feb;96(2):223-235. doi: 10.1007/s00109-017-1619-0. Epub 2017 Dec 30.
10
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.胆管癌不同病因亚型的全基因组和表观基因组景观。
Cancer Discov. 2017 Oct;7(10):1116-1135. doi: 10.1158/2159-8290.CD-17-0368. Epub 2017 Jun 30.